Skip to main content

Table 1 Fold change and adjusted P values for comparison of genes compared in tissues from patients with disease and from healthy controls (see Fig. 1)

From: Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus

  CD38 IGJ TNFSF13B XBP1 IRF4 PRDM1
Groups Fold change Adj. p Fold change Adj. p Fold change Adj. p Fold change Adj. p Fold change Adj. p Fold change Adj. p
OA-healthy 1.31 0.76 1.17 0.95 1.34 0.54 1.50 0.49 1.23 0.86 1.36 0.68
Arthralgia-healthy 4.55 2.50E-04 24.52 5.34E-04 3.48 2.27E-06 2.97 1.04E-03 2.30 0.11 1.23 0.62
UA-healthy 11.84 3.10E-06 516.33 1.86E-07 4.40 1.00E-05 4.35 4.45E-04 6.96 2.74E-03 4.75 1.18E-03
Early RA-healthy 11.20 3.11E-18 123.34 2.02E-15 3.95 1.79E-15 4.44 2.93E-12 8.42 7.15E-11 3.99 8.37E-09
Est. RA-healthy 8.50 3.03E-17 81.75 3.15E-15 3.83 6.63E-17 3.62 5.14E-11 6.33 8.30E-10 3.31 6.15E-08
  1. OA osteoarthrits, UA undifferentiated arthritis, RA rheumatoid arthritis, Est. established, Adj. adjusted